BackBritannia Life Sciences Overview

Britannia Life Sciences Profit Margin

Britannia Life Sciences (BLAB.CN) has a profit margin of 4069.61%, above the Healthcare sector average of 17.63%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

1182.14%
↑ 390.46% YoY

As of Jun 2026

Annual Profit Margin (TTM)

4069.61%
↑ 771.20% YoY

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Britannia Life Sciences (BLAB.CN) FAQ

As of the most recent data (June 2026), BLAB.CN shows a profit margin of 4069.61%. That compares with -606.32% in the prior-year period — up 771.2% year over year. That is above the Healthcare sector average of 17.63%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BLAB.CN's profit margin is now 4069.61% (was -606.32%) — a 771.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Britannia Life Sciences is outperforming or lagging.

The Healthcare sector average profit margin is about 17.63%. Britannia Life Sciences is at 4069.61%, which is higher that average. That is roughly 22985.4% above the sector mean. Use the comparison chart on this page to see how BLAB.CN stacks up against individual peers as well.

That compares with -606.32% in the prior-year period — up 771.2% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Britannia Life Sciences with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Britannia Life Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 4069.61%) with ownership activity and broader fundamentals.

Questions & Answers